With limited scaling potential in tissue banking due to regulatory compliance standards, one way to decrease costs and ultimately increase profits is to optimize the recovery and manufacturing process, which includes reducing the resources needed. There have been several reagents (M and N) that have been highlighted that may help to reduce the time it takes to clean the bone tissue during processing, which equates to a lower production cost.
Organize an experimental plan to test these reagents and develop a pathway for implementation into processing. Include and highlight all controls, assumptions, variables, timeline, etc.
How would you approach a scenario like this?
What factors are needed to be evaluated?
What are your means of determining success?
My approach will be positive.
Tissue banks are a means to obtain tissues like skin, bone etc when needed for transplantation.
The preservation of tissues is very difficult and this requires sterile conditions. The maintenance of sterile conditions is costly and also time consuming. So if we have any alternative of a method that may provide us the required conditions with less time we should opt them.
2.the main factors that are to be evaluated are the sterile conditions of the tissues. Because after tissue transplantation we noticed many diseases like the infections due to bacteria or any other pathogen etc. So we should check for the staerility of the tissue to be transplanted and then go for transplantation.
With limited scaling potential in tissue banking due to regulatory compliance standards, one way to decrease...